- Open Access
Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
Journal of Hematology & Oncology volume 8, Article number: 101 (2015)
It has been brought to our attention that in Fig. two of the article , the immunoblots in the middle panel were incorrectly labeled as TREM2 instead of TMEM140. The correct figure is included below (Fig. 1), in which the immunoblots in the middle panel are labeled as TMEM140. This labeling correction does not affect the results or interpretation of the results. We apologize for this error.
Li B, Huang MZ, Wang XQ, Tao BB, Zhong J, Wang XH, et al. TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol. 2015;8(1):89. doi:10.1186/s13045-015-0187-4.
Bin Li and Ming-Zhu Huang contributed equally to this work.
The online version of the original article can be found under doi:10.1186/s13045-015-0187-4.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Li, B., Huang, MZ., Wang, XQ. et al. Erratum: TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion. J Hematol Oncol 8, 101 (2015). https://doi.org/10.1186/s13045-015-0199-0